|
|
Why Pasithea Therapeutics (KTTA) Stock Is Suddenly On Fire Today
|
|
|
|
Pasithea Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 115.36%
|
|
|
|
Nasdaq Jumps Over 100 Points; Deere Shares Fall After Q4 Results
|
|
|
|
Pasithea Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 113.29%
|
|
|
|
12 Health Care Stocks Moving In Tuesday's After-Market Session
|
|
|
|
Pasithea Therapeutics Awarded $1M By ALS Association
|
|
|
|
Why Keysight Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
|
|
|
|
12 Health Care Stocks Moving In Monday's After-Market Session
|
|
|
|
Shares of Pasithea Therapeutics are trading higher. The company announced PK and PD data from Cohort 7 in its ongoing first-in-human trial evaluating PAS-004 in patients with MAPK pathway-driven advanced solid tumors with a documented RAS, NF1 or RAF mutation, or in patients who have failed prior BRAF/MEK inhibition.
|
|
|
|
Pasithea Reports Results For Pill Aimed At Treating Hard-To-Manage Genetic And Cancer Disorders
|
|